Azelastine Hydrochloride and Fluticasone Propionate | Mylan | ||
0.125mg/Spray; 0.05mg/Spray, Spary, Metered, Nasal |
Less Than $1000 mn
|
||
Less Than 5
|
Less Than 5
|
||
More Than 5
|
Less Than 5
|
||
Less Than 5
|
Less Than 5
|
||
Indicated for the relief of symptoms of seasonal allergic rhinitis in patients 6 years of age and older who require treatment with both azelastine hydrochloride and fluticasone propionate for symptomatic relief. | |||
Yes
|
Dymista | Patent 1 | Patent 2 | Patent 3 | Patent 4 |
---|---|---|---|---|
****** | ******* | ******* | ******* | ******* |
**** | ******* | ******* | ******* | ******* |
******* | ******* | ******* | ******* | ******* |
Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
---|---|---|---|---|---|
****** | *** \ *** | **** *, **** | ******* | ******** | ******** ** * *** **** |
**** | ** \ ** | ***** *, **** | ******* | ********* ******** | ***** *** **** |
******* | ** \ ** | ***** *, **** | ******* | ******** | ******** ** * *** **** |